Increasing Effort by Pharmaceutical Players to Tap the Potential Diabetes Market in China

“Diabetes drug market in China has become a big focus of investment for pharmaceutical companies”, says RNCOS.

 

Noida, UP -- (ReleaseWire) -- 02/19/2014 -- China is progressively moving towards diabetes disaster therby affecting the healthcare expenditure of the country. Approximately 37.2 Million diabetic patients are aware of their condition and this figure might go up in future. As per the increasing diabetes prevalence in China, the healthcare spending is likely to increase in future and growth of health insurance services will provide the market attractive for pharmaceutical players including Novo Nordisk, Sanofi, and Bayer.

However, such a huge potential and attractive market is increasing the investment from several pharmaceutical players. Major pharmaceutical giants are luring in more cash to strategize their foothold in the China diabetes market and increase their market share. They are coming up in the market with new diabetes drugs. Also, the companies have been involved in increasing their production capabilities to gain market share. The country aims to lure more FDI investment in production, R&D to serve the Chinese market. Meanwhile, the government support is also boosting the revenue of the diabetes market.

The report entitled “China Diabetes Market Outlook 2018”, provides an extensive research and in-depth analysis of the segmentation of diabetes market into oral diabetic drug market, insulin drug market, insulin delivery devices market, and glucose monitoring market. . The research covers the market for each segment along with their current and future projections. Our study moreover evaluates the socioeconomic growth pattern throughout the country. It provides an overview of the patient affordability factor, disease prevalence rate and healthcare expenditure on diabetes. The report also discusses the regulatory landscape for diabetes market and current trends and drivers. Moreover, it provides an exhaustive study of the key players with their recent developments and product portfolios. Overall the report is an effective description of China Diabetes Market and will provide the client a source of knowledge and insights on same.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM648.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.